State
72,940 recalls have nationwide distribution and so reach Rhode Island. 3,043 additional recalls listed Rhode Island specifically in their distribution scope.
Of the 3,043 recalls naming Rhode Island we have scored against our rubric, 221 (7%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 570 (19%) are Severe.
Which agencies issued them
These figures cover only the 3,043 recalls whose distribution notice names Rhode Island specifically. The 72,940 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
About 1,100 Wilteexs bioethanol fuel bottles are being recalled because they lack the flame mitigation devices required by the Portable Fuel Container Safety Act.
CareFusion is recalling BD Alaris Pump Infusion Sets because the pump module used with them may perform outside established ranges for flow rate, bolus accuracy and occlusion alarm timing.
Abiomed is recalling 10,153 Automated Impella Controllers over potential cybersecurity vulnerabilities related to the controller's operating system.
GenoGenix is recalling NAD+ for Injection at 100 mg/mL and 200 mg/mL from one lot for microbial contamination of sterile products, with elevated endotoxin levels.
BMW is recalling 2018 328D diesel vehicles because a leaking EGR cooler can cause smoldering particles and a melting intake manifold, increasing the risk of a fire.
International is recalling 2026 IC Bus CESB school buses because a transmission shift actuator may not be calibrated properly, preventing reverse gear engagement.
Winnebago is recalling specific travel trailers because the Federal tire label may list the incorrect tire size, creating a risk of installing the wrong tire.
GenoGenix is recalling Ultra Burn for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GE is recalling 7,302 AW Server systems after identifying a security vulnerability that, if exploited, could compromise the confidentiality, integrity and availability of patient data.
GenoGenix is recalling Calcium Chloride for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling Retatrutide for Injection, 60mg/10mL vial, from a single lot for lack of assurance of sterility.
GenoGenix is recalling L-Glutamine for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling Taurine for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling Tesamorelin for Injection, 15mg in a 10 mL multi-dose vial, from a single lot for lack of assurance of sterility.
GenoGenix is recalling Oxytocin for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling NAD+ injection at 50 mg/mL and 100 mg/mL in 10 mL multi-dose vials, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling Elite Stack MSC Exosome Reconstitution Solution for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling Bacteriostatic Water for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
Applied Medical Technology is recalling 390 NutraGlide nasal feeding tubes whose distal tips may detach at lower than expected forces.
Accord Healthcare is recalling 54,432 bottles of Levothyroxine Sodium Tablets USP 88 mcg after long-term stability testing found assay content below the approved specification range.
GenoGenix is recalling L-Arginine for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling preserved Ascorbic Acid (Vitamin C) for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
Major Pharmaceuticals is recalling 1,394 blister packs of Chlorpromazine Hydrochloride Tablets USP 200 mg because N-Nitroso Desmethyl Chlorpromazine was present above the recommended intake limit.
GenoGenix is recalling EDTA for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling Zinc Chloride for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.